Novavax to sell Czech manufacturing unit to Novo Nordisk

Novavax to sell Czech manufacturing facility to Novo Nordisk for $200M
Novavax (NASDAQ:NVAX) is selling its manufacturing facility in the Czech Republic to Novo Nordisk (NVO) for $200M. The Gaithersburg, Maryland-based biotech has been grappling with lower sales of its only marketed product,
Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 million
By Gnaneshwar Rajan and Maggie Fick (Reuters) -U.S.-based vaccine maker Novavax said on Wednesday it will sell its manufacturing facility in the Czech Republic to Wegovy maker Novo Nordisk for $200 million and use the proceeds for its vaccine pipeline.
Novavax to sell Bohumil manufacturing facility to Novo Nordisk for USD 200 million
Gaithersburg: Novavax, Inc., a global company advancing protein-based vaccines with its Matrix-M adjuvant, today announced that it has signed a definitive agreement to sell its
Novavax To Sell Manufacturing Facility In Bohumil, Czech Republic To Novo Nordisk For $200 Mln
Novavax Inc. (NVAX) said that it agreed to sell its manufacturing facility in Bohumil, Czech Republic to Novo Nordisk for $200
Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 mln
COVID-19 vaccine maker Novavax said on Wednesday it will sell its manufacturing facility in Czech Republic to Wegovy-maker Novo Nordisk for $200 million and use the proceeds for its vaccine pipeline.
Novavax sells Czech manufacturing facility to Novo Nordisk for $200 mn
The divestiture of the Czech facility follows U.S.-based Novavax's licensing deal worth at least $1.2 billion with French drugmaker Sanofi for its COVID-19 vaccine, in exchange for the latter taking a
ETFs tracking securitized debt, AI and Novo Nordisk add to industry’s banner 2024
Three separate asset management firms launched exchange-traded funds on Tuesday, unveiling products focused on securitized ...
STAT20h
Pharmalittle: We’re reading about menopause treatments, Novo plans for Wegovy in India, and more
Yet at the annual meeting of the Menopause Society earlier this fall, researchers presented new evidence that hormone therapy ...
FierceBiotech4h
Novo Holdings-backed Antag raises $84M series A to send complementary obesity candidate to the clinic
Antag Therapeutics thinks its glucose dependent insulinotropic polypeptide receptor (GIPR) antagonist could carve out a space ...
Is Novo Nordisk Stock a Buy?
Few companies garner as much reliable attention as Novo Nordisk ( NVO) does these days. With a bull market coinciding with a ...
Novo Nordisk to present new data highlighting innovative rare blood disorders pipeline at ASH 2024
Novo Nordisk today announced the presentation of 13 abstracts at the upcoming 66th Annual Meeting and Exposition of the American Society of Hematology (ASH), which will take place from 7 to 10 ...
Novo Nordisk Announces Major Share Buyback Program
Novo Nordisk (NVO) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - Now At 40% ...
Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
Novo Nordisk's team in India is urging the company to launch its popular weight-loss drug, Wegovy, next year to stay ahead of ...
Diversity helps identify leaders at Novo Nordisk
When leaders at Novo Nordisk Canada Inc. (NNCI) wanted to focus on diversity, equity, inclusion and belonging efforts for ...